跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RELISTOR methylnaltrexone bromide 12 mg/0.6 mL solution for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
RELISTOR methylnaltrexone bromide 12 mg/0.6 mL solution for injection vial
Approved
STANDARD
RELISTOR methylnaltrexone bromide 12 mg/0.6 mL solution for injection vial
Link Medical Products Pty Ltd T/A Link Pharmaceuticals
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
7e251dcc69e95cc5
Company
Link Medical Products Pty Ltd T/A Link Pharmaceuticals
Type
Standard
Approval Details
Approval Id
7e251dcc69e95cc5
Product Name
RELISTOR methylnaltrexone bromide 12 mg/0.6 mL solution for injection vial
Artg Id
144062
Artg Name
RELISTOR methylnaltrexone bromide 12 mg/0.6 mL solution for injection vial
Sponsor
Link Medical Products Pty Ltd T/A Link Pharmaceuticals
Artg Date
2008-11-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/c7c59531c8002c4e0ee160d1b0dfad67.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/79c02dd652ee1b9df6b919e1d413116b.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
7e251dcc69e95cc5
Type
Standard
Back to TGA Approvals